** Shares of Medibank Private MPL.AX rise as much as 3.9% to a record high of A$4.502, last up 2.8%
** UBS hikes price target for insurer to A$4.90 from A$4.30, rates stock "Buy"
** Brokerage sees scope for gross margins to expand further into FY26E, given that premium rate rises are set to continue outpacing inflation in near term
** Three of 10 analysts rate the stock "buy" and seven "hold"; median PT is A$4.46 – data compiled by LSEG
** Stock up 17.9% this year
(Reporting by Nichiket Sunil in Bengaluru)
((Nichiket.Sunil@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。